Evidence map›Paper›PMID 42337231›Full record

ArticleBlood cancer journal2026

Venetoclax combined with intensive chemotherapy as induction chemotherapy in newly diagnosed AML with FLT3-ITD-mutation.

Yuyu Liu, Guanchen Bai, Xingli Zhao, Xiaohui Suo, Yanliang Bai, Fang Zheng, Weihua Zhao, Hongling Peng, Dongmei Wang, Liyun Zhao and 5 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuyu Liu *Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
Guanchen Bai *Department of Hematology, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, Shandong, China.
Xingli Zhao *Department of Hematology, Oncology Center, Tianjin Union Medical Center, The First Affiliated Hospital of NanKai University, NanKai University, Tianjin, China.
Xiaohui Suo *Department of Hematology, Handan Central Hospital, Hebei, China.
Yanliang Bai *Department of Hematology, Zhengzhou University People's Hospital and Henan Provincial People's Hospital, Zhengzhou, China.
Fang Zheng *Department of Hematology, The Second People's Hospital of Guiyang, Guiyang, Guizhou, China.
Weihua ZhaoDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Hongling PengDepartment of Hematology, The Second Xiangya Hospital of Central South University, Changsha, China.ORCID http://orcid.org/0000-0003-2770-5150
Dongmei WangDepartment of Hematology, Harrison International Peace Hospital, Hengshui, Hebei, China.
Liyun ZhaoDepartment of Hematology, People's Hospital of XingTai, Hebei, China.
Jie LiuDepartment of Hematology, Sinopharm Tongmei General Hospital, Datong, Shanxi, China.
Ling LiDepartment of Hematology, Inner Mongolia People's Hospital, Huhehaote, Neimenggu, China.
Zeping ZhouDepartment of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. zhouzeping@kmmu.edu.cn.ORCID http://orcid.org/0000-0002-7698-7695
Yingchang MiNational Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China. ychmi@ihcams.ac.cn.ORCID http://orcid.org/0000-0002-5060-5070
Kaiqi LiuNational Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China. liukaiqi@ihcams.ac.cn.ORCID http://orcid.org/0000-0002-1532-0301

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42337231
PMCPMC13291227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.